37P Pralsetinib in acquired RET fusion-positive advanced non-small cell lung cancer patients after resistance to EGFR/ALK-TKI: A China multi-center, real-world data (RWD) analysis

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

18

Issue :

4, Number 4 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs62897050

Full Text :

https://doi.org/10.1016/S1556-0864(23)00291-5